
Evaluation of magnetic resonance imaging sensitivity in patients with relapsing remitting multiple sclerosis: baseline versus Betaseron treatment trials.
Publication
, Journal Article
Frank, JA; Bash, C; Stone, L; Petrella, J; Maloni, H; McFarland, H
Published in: Acad Radiol
August 1996
Duke Scholars
Published In
Acad Radiol
DOI
ISSN
1076-6332
Publication Date
August 1996
Volume
3 Suppl 2
Start / End Page
S173 / S175
Location
United States
Related Subject Headings
- Pentetic Acid
- Organometallic Compounds
- Nuclear Medicine & Medical Imaging
- Nerve Fibers, Myelinated
- Multiple Sclerosis
- Middle Aged
- Meglumine
- Male
- Magnetic Resonance Imaging
- Interferon-beta
Citation
APA
Chicago
ICMJE
MLA
NLM
Frank, J. A., Bash, C., Stone, L., Petrella, J., Maloni, H., & McFarland, H. (1996). Evaluation of magnetic resonance imaging sensitivity in patients with relapsing remitting multiple sclerosis: baseline versus Betaseron treatment trials. Acad Radiol, 3 Suppl 2, S173–S175. https://doi.org/10.1016/s1076-6332(96)80525-3
Frank, J. A., C. Bash, L. Stone, J. Petrella, H. Maloni, and H. McFarland. “Evaluation of magnetic resonance imaging sensitivity in patients with relapsing remitting multiple sclerosis: baseline versus Betaseron treatment trials.” Acad Radiol 3 Suppl 2 (August 1996): S173–75. https://doi.org/10.1016/s1076-6332(96)80525-3.
Frank JA, Bash C, Stone L, Petrella J, Maloni H, McFarland H. Evaluation of magnetic resonance imaging sensitivity in patients with relapsing remitting multiple sclerosis: baseline versus Betaseron treatment trials. Acad Radiol. 1996 Aug;3 Suppl 2:S173–5.
Frank, J. A., et al. “Evaluation of magnetic resonance imaging sensitivity in patients with relapsing remitting multiple sclerosis: baseline versus Betaseron treatment trials.” Acad Radiol, vol. 3 Suppl 2, Aug. 1996, pp. S173–75. Pubmed, doi:10.1016/s1076-6332(96)80525-3.
Frank JA, Bash C, Stone L, Petrella J, Maloni H, McFarland H. Evaluation of magnetic resonance imaging sensitivity in patients with relapsing remitting multiple sclerosis: baseline versus Betaseron treatment trials. Acad Radiol. 1996 Aug;3 Suppl 2:S173–S175.

Published In
Acad Radiol
DOI
ISSN
1076-6332
Publication Date
August 1996
Volume
3 Suppl 2
Start / End Page
S173 / S175
Location
United States
Related Subject Headings
- Pentetic Acid
- Organometallic Compounds
- Nuclear Medicine & Medical Imaging
- Nerve Fibers, Myelinated
- Multiple Sclerosis
- Middle Aged
- Meglumine
- Male
- Magnetic Resonance Imaging
- Interferon-beta